159 results match your criteria: "and Clinical Ethics[Affiliation]"
Acta Paediatr
November 2014
Neonatology and Clinical Ethics, Université de Montréal, Sainte-Justine Hospital, Montreal, QC, Canada.
Aim: Technological and clinical advances have reduced neonatal deaths, and this study explored how the mode and timing of neonatal deaths has changed in a tertiary neonatal intensive care unit (NICU) over 10 years.
Methods: We carried out a retrospective chart review on NICU deaths in 2000-2002 and 2007-2010, categorising deaths and compared the timing, cause and mode of death in the two cohorts.
Results: We analysed 204 neonatal deaths and found that the average age at death doubled from 9.
JAMA Pediatr
June 2014
Division of Neonatology and Clinical Ethics, Sainte-Justine Hospital, University of Montreal, Montreal, Quebec, Canada.
Indian J Endocrinol Metab
March 2014
Departments of Internal Medicine and Clinical Ethics, St John's Medical College, Bangalore, Karnataka, India.
Chest
April 2014
Division of Pulmonary, Allergy, and Critical Care, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY. Electronic address:
Extracorporeal membrane oxygenation (ECMO) can serve as a bridge to recovery in cases of acute reversible illness, a bridge to transplantation in circumstances of irreversible cardiac or respiratory failure, a bridge to ventricular assist device therapy in select cases of cardiac failure, or a bridge to decision when the prognosis remains uncertain. Recent advances in ECMO technology that allow for prolonged support with decreased complications, the development of mobile ECMO teams, the rapidity of initiation, and the growing body of evidence, much of which remains controversial, have led to a significant increase in the use of ECMO worldwide. This increasing use of a technology that is not a destination device in itself introduces many ethical dilemmas specific to this technology.
View Article and Find Full Text PDFPaediatr Child Health
January 2014
Pediatrics, Neonatologist, Director of Pediatrics, University Medical Center Groningen, Groningen, Netherlands.
Paediatr Child Health
February 2014
Section of Pediatric Neurosciences, Department of Pediatrics, University of Alberta, Edmonton, Alberta.
Semin Perinatol
February 2014
The DeVeber Center for Bioethics and Social Research, Canada; Patients for Patient Safety Canada, Canada.
The nature and content of the conversations between the healthcare team and the parents concerning withholding or withdrawing of life-sustaining interventions for neonates vary greatly. These depend upon the status of the infant; for some neonates, death may be imminent, while other infants may be relatively stable, yet with a potential risk for surviving with severe disability. Healthcare providers also need to communicate with prospective parents before the birth of premature infants or neonates with uncertain outcomes.
View Article and Find Full Text PDFSemin Perinatol
February 2014
Department of Pediatrics and Clinical Ethics, University of Montreal; Neonatology and Clinical Ethics, Sainte-Justine Hospital, Montreal, Quebec, Canada H3T 1C5.
Interventions for extremely preterm infants bring up many ethical questions. Guidelines for intervention in the "periviable" period generally divide infants using predefined categories, such as "futile," "beneficial," and "gray zone" based on completed 7-day periods of gestation; however, such definitions often differ among countries. The ethical justification for using gestational age as the determination of the category boundaries is rarely discussed.
View Article and Find Full Text PDFVirtual Mentor
December 2013
Director of the adult palliative medicine service, and co-director of the Center for Supportive Care and Clinical Ethics in the Department of Medicine at Columbia University Medical Center in New York City.
Acta Paediatr
December 2013
Department of Pediatrics and Clinical Ethics, Neonatology and Clinical Ethics, Sainte-Justine Hospital, University of Montreal, Montreal, QC, Canada.
Unlabelled: Children with trisomy 13 and trisomy 18 (T13 or T18) have low survival rates, and survivors have significant disabilities. Life saving interventions (LSIs) are generally not recommended by many healthcare providers (HCPs). After a diagnosis of T13 or T18, many parents chose termination of pregnancy or comfort care at birth, but others consider treatment to prolong the lives of their children.
View Article and Find Full Text PDFJ Perinatol
May 2013
Department of Pediatrics and Clinical Ethics, University of Montreal, Neonatologist and Clinical Ethicist, Sainte-Justine Hospital, Montreal, QC, USA.
Acta Paediatr
July 2013
Department of Pediatrics and Clinical Ethics, Neonatologist and Clinical Ethics, Sainte-Justine Hospital, Sainte-Justine Hospital Research Center, University of Montreal, Montreal, QC, Canada.
Pediatrics
August 2012
Department of Pediatrics and Clinical Ethics, University of Montreal, Neonatologist and Clinical Ethicist, Sainte-Justine Hospital, 3175 Chemin Côte-Sainte-Catherine, Montreal (QC), H3T 1C5 Canada.
Background: Children with trisomy 13 and trisomy 18 (T13-18) have low survival rates and survivors have significant disabilities. For these reasons, interventions are generally not recommended by providers. After a diagnosis, parents may turn to support groups for additional information.
View Article and Find Full Text PDFAddict Biol
May 2014
Department of Neuropsychiatry and Clinical Ethics, Graduate School of Medical Science, University of Yamanashi, Chuo, Yamanashi, Japan; Department of Medical Genetics, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan.
We have previously shown that a haplotype associated with decreased NrCAM expression in brain is protective against addiction vulnerability for polysubstance abuse in humans and that Nrcam knockout mice do not develop conditioned place preferences for morphine, cocaine or amphetamine. In order to gain insight into NrCAM involvement in addiction vulnerability, which may involve specific neural circuits underlying behavioral characteristics relevant to addiction, we evaluated several behavioral phenotypes in Nrcam knockout mice. Consistent with a potential general reduction in motivational function, Nrcam knockout mice demonstrated less curiosity for novel objects and for an unfamiliar conspecific, showed also less anxiety in the zero maze.
View Article and Find Full Text PDFActa Paediatr
August 2012
Division of Neonatology and Clinical Ethics, Department of Pediatrics, University of Montreal, Sainte-Justine Hospital, Montreal, QC, Canada.
Unlabelled: When physicians are asked for a consult for women in premature labour, they face a complex set of challenges. Policy statements recommend that women be given detailed information about the risks of various outcomes, including death, long-term disability and various specific neonatal problems. Both personal narratives and studies suggest that parents also base their decisions on factors other than the probabilistic facts about expected outcomes.
View Article and Find Full Text PDFJ Pain Symptom Manage
April 2012
Hospice and Palliative Medicine, Division of Geriatric Medicine, and Clinical Ethics, Department of Medicine, Winthrop University Hospital, Mineola, NY, USA.
Patients in the advanced stages of amyotrophic lateral sclerosis often are faced with the dilemma of whether to use or continue to use mechanical ventilation. Patients who elect to terminate ventilatory support may be subject to significant and even extreme respiratory symptoms. Severe dyspnea and other symptoms are sometimes treated with palliative sedation, which is generally recommended as a last resort approach to refractory symptoms.
View Article and Find Full Text PDFJ Paediatr Child Health
September 2011
General Medicine and Clinical Ethics, The Children's Hospital at Westmead, New South Wales, Australia.
More than ever before, public institutions are expected to have accessible guidelines on what they do, both for their staff and for those served by them. With this in mind, some principles of treatment and care of sick children were drafted for the Children's Hospital at Westmead. These were centred on ethics, primarily of what was best for the child.
View Article and Find Full Text PDFNeonatology
July 2012
Department of Neonatology, Women's and Children's Division and Clinical Ethics Committee, Oslo University Hospital HC-Rikshospitalet, Oslo, Norway.
Many advances have occurred in clinical medicine in the last decades. Solid organ transplants, corrective surgery for congenital malformations, improved cytostatic regimes for children with cancer, and respiratory care for premature infants are but a few examples of the changing face of medical practice. Such changes have added years to life.
View Article and Find Full Text PDFCurr Probl Pediatr Adolesc Health Care
April 2011
University of Montreal, Neonatology and Clinical Ethics, Sainte-Justine Hospital, Montreal, Quebec, Canada.
J Pediatr
August 2011
Pediatrics and Clinical Ethics, Université de Montréal, Montréal, Québec, Canada.
Objectives: To clarify the use of end-of-life comfort medications or neuromuscular blockers (NMBs) in culturally different neonatal intensive care units (NICUs).
Study Design: Review of medical files of newborns > 22 weeks gestation who died in the delivery room or the NICU during 12 months in four NICUs (Chicago, Milwaukee, Montreal, and Groningen). We compared use of end-of-life comfort medications and NMBs.
Arch Dis Child
April 2010
Consultant in Paediatrics and Clinical Ethics, Great Ormond Street Hospital NHS Trust, Great Ormond Street, London WC1N 3JH, UK.
Competence is an essential legal requirement for valid consent to medical treatment. Children under 16 may be considered 'Gillick competent' to make treatment decisions, but may need to demonstrate this. Applied tests for competence are wide-ranging and context dependent.
View Article and Find Full Text PDFNihon Rinsho
September 2007
Department of Neuropsychiatry and Clinical Ethics, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi.
Electroconvulsive therapy(ECT) is one of the most important methods in treating depressive patients especially who can not be improved with medication. Meta analysis shows that ECT is superior to pharmacotherapy as acute treatment for depression. ECT was invented in 1938, and it took some improvement afterwards such as development of modified ECT and introduction of brief-pulse stimulation for the purpose of reducing adverse effects.
View Article and Find Full Text PDFMed Ethics (Burlingt Mass)
January 2007
Center for Palliative Care and Clinical Ethics, University of Rochester Medical Center, USA.